Headlands Technologies’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Buy |
12,644
+1,929
| +18% | +$64.2K | 0.05% | 341 |
|
|
2025
Q1 | $314K | Sell |
10,715
-16,021
| -60% | -$469K | 0.04% | 369 |
|
|
2024
Q4 | $879K | Buy |
26,736
+12,989
| +94% | +$427K | 0.09% | 239 |
|
|
2024
Q3 | $611K | Buy |
13,747
+2,297
| +20% | +$102K | 0.07% | 303 |
|
|
2024
Q2 | $494K | Buy |
+11,450
| New | +$494K | 0.05% | 282 |
|
|
2024
Q1 | – | Sell |
-8,893
| Closed | -$198K | – | 1224 |
|
|
2023
Q4 | $198K | Sell |
8,893
-144
| -2% | -$3.21K | 0.06% | 279 |
|
|
2023
Q3 | $224K | Buy |
9,037
+2,153
| +31% | +$53.3K | 0.11% | 186 |
|
|
2023
Q2 | $195K | Buy |
+6,884
| New | +$195K | 0.06% | 283 |
|